Hodgkin lymphoma (HL) is a type of cancer that ... components of treatment for relapsed or refractory HL is stem cell transplantation, particularly autologous hematopoietic cell transplantation ...

Results of 3 trials revealed that omitting transplant did not impact progression or survival outcomes for pediatric, ...

A new study shows that oral fecal microbiota transplantation (FMT) is a feasible and safe addition to preventing ...

Dana-Farber Cancer Institute researchers have identified factors that determine whether donor lymphocyte infusion (DLI), a ...

A new study shows that oral fecal microbiota transplantation (FMT) is a feasible and safe addition to preventing graft-versus-host disease in patients undergoing stem cell transplantation for blood ...

Kinase Inhibitors These drugs block certain enzymes that control cell growth, helping to keep lymphoma cells from growing ... parts of the immune system. Stem cells are removed from the blood ...

Caregiving can take many forms, often requiring a profound shift in daily life. While navigating a disease is an immense challenge for patients, managing the emotional, logistical and personal burdens ...

The Food and Drug Administration has granted traditional approval to Calquence with bendamustine and Rituxan for some ...

The conversion of Calquence’s accelerated approval in mantle cell lymphoma comes a day before the drug was listed among the ...

The drug received accelerated approval in October 2017 as monotherapy for adults with MCL who have received at least one ...

AstraZeneca (NASDAQ:AZN) announced Friday that the U.S. FDA approved its Bruton’s tyrosine kinase (BTK) inhibitor Calquence ...

The Food and Drug Administration (FDA) has approved Calquence ® (acalabrutinib) in combination with bendamustine and rituximab for the treatment of adults with previously untreated mantle cell ...